News

Transcranial Electrical Stimulation Effective for Insomnia

TOPLINE: Transcranial alternating current stimulation (tACS), a noninvasive technique that uses low-intensity electrical currents to modulate brain activity, is an effective intervention for treating chronic insomnia, especially in older people, results of a relatively large study suggested. METHODOLOGY: The double-blind study included 124 adults with chronic insomnia (difficulty falling asleep or maintaining sleep and early

Prisoner First, Patient Second

Prisoner First, Patient Second

MedPage Today) — As physicians at one of the largest public hospitals in the country, we have left some patient interactions feeling demoralized. This occurs most often when it is clear that medical interventions are incapable of overcoming the…

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, according to a study published online Nov. 27 in eClinicalMedicine. Fumiki Yoshihara, from the National Cerebral and Cardiovascular Center in Osaka, Japan, and colleagues conducted a multicenter, randomized trial that enrolled

tDCS Promising for Improved Cognition in Alzheimer’s

TOPLINE: Transcranial direct current stimulation (tDCS) delivered twice daily over 6 weeks can improve cognitive function in patients with Alzheimer’s disease (AD), highlighting the potential of tDCS as a therapeutic intervention, new research shows.  METHODOLOGY: The study enrolled 124 patients with mild to moderate AD, with 63 randomly allocated to receive active tDCS and 61

Study to Examine Routine ICD Implantation Post Heart Attack

PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of Cardiology is a partner in this large-scale trial. Implantable Cardioverter Defibrillators (ICDs) Heart attack survivors are at an increased risk for death…